Cationic microemulsion of voriconazole for the treatment of fungal keratitis: in vitro and in vivo evaluation

被引:2
|
作者
Mohan, Parasuraman [1 ,2 ]
Rajeswari, Jothimani [1 ]
Kesavan, Karthikeyan [1 ]
机构
[1] Guru Ghasidas Vishwavidyalaya Cent Univ, Dept Pharm, Bilaspur 495009, CG, India
[2] Vellalar Coll Pharm, Dept Pharmaceut, Erode 638012, Tamil Nadu, India
关键词
anti-fungal; cationic microemulsion; chitosan-coated microemulsion; cremophore EL; fungal keratitis; linoleic acid; mucoadhesive; ocular irritation; propylene glycol; voriconazole; POSITIVELY CHARGED MICROEMULSIONS; OCULAR DRUG-DELIVERY; BETA-CYCLODEXTRIN; CHITOSAN; DEXAMETHASONE; OPTIMIZATION; FORMULATION; PERMEATION; LIPOSOMES;
D O I
10.4155/tde-2023-0069
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: This investigation aimed to develop a voriconazole-loaded chitosan-coated cationic microemulsion (CVME) to treat fungal keratitis. Methods: Microemulsions were prepared using water titration, and the optimized microemulsion was coated with chitosan to prepare CVME. The physicochemical parameters, ocular irritation potential, in vitro antifungal efficacy and in vitro release studies were performed. The in vivo antifungal efficacy study was conducted in a fungal infection-induced rabbit eye model. Results: The developed CVME displayed acceptable physicochemical properties and excellent mucoadhesive behavior and showed a sustained release profile. Ex vivo and in vivo studies concluded that higher permeability and improved antifungal efficacy were observed for CVME than drug suspension (DS). Conclusion: The prepared CVME7 is a viable alternative to treating fungal keratitis with existing approaches.
引用
收藏
页码:23 / 39
页数:18
相关论文
共 50 条
  • [1] Mucoadhesive Chitosan-Coated Cationic Microemulsion of Dexamethasone for Ocular Delivery: In Vitro and In Vivo Evaluation
    Kesavan, Karthikeyan
    Kant, Shri
    Singh, Paras Nath
    Pandit, Jayanta Kumar
    CURRENT EYE RESEARCH, 2013, 38 (03) : 342 - 352
  • [2] Development of a Luliconazole Nanoemulsion as a Prospective Ophthalmic Delivery System for the Treatment of Fungal Keratitis: In Vitro and In Vivo Evaluation
    Yang, Jingjing
    Liang, Zhen
    Lu, Ping
    Song, Fei
    Zhang, Zhen
    Zhou, Tianyang
    Li, Jingguo
    Zhang, Junjie
    PHARMACEUTICS, 2022, 14 (10)
  • [3] Factors Affecting Treatment Outcomes With Voriconazole in Cases With Fungal Keratitis
    Ramakrishnan, Thushanthi
    Constantinou, Marios
    Jhanji, Vishal
    Vajpayee, Rasik B.
    CORNEA, 2013, 32 (04) : 445 - 449
  • [4] Successful treatment of Beauveria bassiana fungal keratitis with topical voriconazole
    Ogawa, Akiko
    Matsumoto, Yukihiro
    Yaguchi, Takashi
    Shimmura, Shigeto
    Tsubota, Kazuo
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2016, 22 (04) : 257 - 260
  • [5] Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis
    Cai, Jingjing
    Yang, Chengwen
    Wei, Qiuhong
    Lian, Huifang
    An, Lin
    Zhang, Rong
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (03) : 775 - 779
  • [6] Natamycin versus voriconazole for fungal keratitis
    Retamal, Jose
    Ordenes-Cavieres, Gonzalo
    Grau-Diez, Arturo
    MEDWAVE, 2018, 18 (08):
  • [7] Combination of Intracameral and Intrastromal Voriconazole in the Treatment of Recalcitrant Acremonium Fungal Keratitis
    Haddad, Randa S.
    El-Mollayess, Georges M.
    MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2012, 19 (02) : 265 - 268
  • [8] Combined Intrastromal Voriconazole and Amphotericin B Treatment for Persistent Fungal Keratitis
    Aydin, Bahri
    Cubuk, Mehmet Ozgur
    Ucgul, AhmetYucel
    Ertop, Mestan
    Ozmen, Mehmet Cuneyt
    Atalay, Tuba
    Akata, Fikret
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2020, 46 (05): : 269 - 273
  • [9] Amphotericin B versus Voriconazole in the treatment of fungal keratitis: a comparative study
    Mervat, Mourad S.
    Ahmad, Ahmad H.
    JOURNAL OF THE EGYPTIAN OPHTHALMOLOGICAL SOCIETY, 2022, 115 (01) : 7 - 22
  • [10] Voriconazole in fungal keratitis caused by Scedosporium apiospermum
    Prats, CH
    Tello, FL
    San José, AB
    Otaolaurruchi, JS
    Baines, JPO
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (03) : 414 - 417